DesignMedix gets $3m NIH grant to develop low-cost malaria drug - 1 views
-
Alex Parker on 17 Apr 14US-based biotech startup DesignMedix has received a grant of $3m from the National Institutes of Health (NIH) to continue the development and manufacturing of a new anti-malarial drug.